Dana Farber Cancer Institute ( Site 0101)
Boston, Massachusetts 02215
0 studies enrolling now · 1 studies all time
What they study most
Advanced Melanoma
Studies at this site
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
— Stopped early